ITMCTR2100005101
Completed
Phase 1
Optimization of prevention and treatment strategies for treating hand, foot and mouth with fever and rash syndrome
Beijing Youan Hosptial, Captial Medical University0 sitesTBD
ConditionsHand-foot-and-mouth disease
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Hand-foot-and-mouth disease
- Sponsor
- Beijing Youan Hosptial, Captial Medical University
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The diagnosis of mild HFMD was established (Ministry of Health of the Peoples Republic of China, 2018\) according the guidelines for the diagnosis and treatment of HFMD issued by the Ministry of Health of China in 2018\. In addition, ages of children should be within the range of 1 to 5 years, the occurrence of fever or skin and oral mucosal lesions were no more than 48 hours after , and the body temperatures were between 37\.5 degree C to 38\.5 degree C. All patients and their guardians agreed and informed consent forms before enrollment.
Exclusion Criteria
- •Patients had neurogenic pulmonary edema or heart or respiratory failure, chronic hepatitis, congenital heart disease, or acute or chronic nephritis; had a history of allergy to herbal medicine, or mild increases in bilirubin, intravascular hemolysis. Patients had been taken other Chinese herbal medicines or antivirals, hormonal therapy or participated in other clinical studies on HFMD, and had any condition that could have interfered with the evaluation of the study objectives.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Comparison between Andrographolide Sulfonate, No.2 Qing Re Jie Du decoction and Conventional Therapy in the Treatment of Severe Hand, Foot, and Mouth Disease: A Prospective Randomized Controlled&#Hand-foot-and-mouth diseaseITMCTR2100005100Beijing Youan Hosptial, Captial Medical University
Not yet recruiting
Phase 1
A study on strategies for the prevention and treatment of metabolic syndrome in Chinese medicine and the preliminary construction of a predictive model for cardiovascular disease risk - a prospective cohort studyITMCTR2022000037Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Recruiting
Not Applicable
ovel strategies of preventions and therapies for esophageal cancer using bioactive molecules derived from oral flora or probioticsesophageal squamous cell carcinoma, esophageal adenocarcinoma, esophageal squamous dysplasia, Barrett's esophagusJPRN-UMIN000025105Asahikawa Medical University60
Completed
Not Applicable
Interventional study to optimize the preventive behavior in first-degree relatives of patients with colorectal carcinomaColorectal carcinoma (CRC) prevention, the preventive behavior in first-degree relativesC26.0Intestinal tract, part unspecifiedDRKS00006818Medizinische Klinik II,Onkologie / Hämatologie und Sektion Pneumologie,Hubertus Wald Tumorzentrum,Universitäres Cancer Center (UCCH),Universitätsklinikum Eppendorf215
Not yet recruiting
Phase 1
The efficacy and safety of chinese herbal medicine Shen-Qi Hua-Yu formula in patients with diabetic lower extremity artery disease: a multi-centre, randomized, double-blind, placebo-controlled trialDiabetic Lower Extremity Artery DiseaseITMCTR1900002645Hospital of Chengdu University of Traditional Chinese Medicine